Histopathological work-up and interpretation of sentinel lymph nodes removed for vulvar squamous cell carcinoma

Histopathology

Volumn 55, Issue 2, 2009, Pages 174-181

  Regauer, Sigrid ^a  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

Author keywords

Lichen sclerosus; Micrometastases; Vulvar carcinoma

Indexed keywords

CYTOKERATIN ANTIBODY; EOSIN; FORMALDEHYDE; HEMATOXYLIN;

ADULT; AGED; ARTICLE; CANCER PATIENT; CANCER STAGING; CELL NUCLEUS; CELL STRUCTURE; CLINICAL ARTICLE; EVALUATION; FEMALE; FROZEN SECTION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INGUINAL LYMPH NODE; LICHEN SCLEROSUS ET ATROPHICUS; LYMPHADENECTOMY; METASTASIS; MICROMETASTASIS; PRIORITY JOURNAL; SCREENING; SENTINEL LYMPH NODE; SQUAMOUS CELL CARCINOMA; STAINING; TUMOR CELL; VULVA CARCINOMA;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; FEMALE; FROZEN SECTIONS; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPH NODE EXCISION; LYMPH NODES; LYMPHATIC METASTASIS; MIDDLE AGED; NEOPLASM STAGING; PRACTICE GUIDELINES AS TOPIC; SENTINEL LYMPH NODE BIOPSY; VULVAR NEOPLASMS;

EID: 68849119599     PISSN: 03090167     EISSN: 13652559     Source Type: Journal    
DOI: 10.1111/j.1365-2559.2009.03350.x     Document Type: Article

References (25)

1. Hacker NF, Leuchter RS, Berek JS, Castaldo TW, Lagasse LD. Radical vulvectomy and bilateral inguinal lymphadenectomy through separate groin incisions. Obstet. Gynecol. 1981 58 574 579.
2. Burger MP, Hollema H, Emanuels AG, Krans M, Pras E, Bouma J. The importance of the groin node status for the survival of T1 and T2 vulval carcinoma patients. Gynecol. Oncol. 1995 57 327 334.
3. Bell JG, Lea JS, Reid GC. Complete groin lymphadenectomy with preservation of the fascia lata in the treatment of vulvar carcinoma. Gynecol. Oncol. 2000 77 314 318.
4. Knopp S, Nesland JM, Trope C. SLNB and the importance of micrometastases in vulvar squamous cell carcinoma. Surg. Oncol. 2008 17 219 225.
5. Robison K, Steinhoff MM, Granai CO, Brard L, Gajewski W, Moore RG. Inguinal sentinel node dissection versus standard inguinal node dissection in patients with vulvar cancer: a comparison of the size of metastasis detected in inguinal lymph nodes. Gynecol. Oncol. 2006 101 24 27. (Pubitemid 43303555)
6. Rouzier R, Haddad B, Dubernard G, Dubois P, Paniel BJ. Inguinofemoral dissection for carcinoma of the vulva: effect of modifications of extent and technique on morbidity and survival. J. Am. Coll. Surg. 2003 196 442 450.
7. Gaarenstroom KN, Kenter GG, Trimbos JB et al. Postoperative complications after vulvectomy and inguinofemoral lymphadenectomy using separate groin incisions. Int. J. Gynecol. Cancer 2003 13 522 527.
8. Moore RG, DePasquale SE, Steinhoff MM et al. Sentinel node identification and the ability to detect metastatic tumor to inguinal lymph nodes in squamous cell cancer of the vulva. Gynecol. Oncol. 2003 89 475 479.
9. Terada KY, Shimizu DM, Jiang CS, Wong JH. Outcomes for patients with T1 squamous cell cancer of the vulva undergoing sentinel node biopsy. Gynecol. Oncol. 2006 102 200 203.
10. Van der Zee AG, Oonk MH, De Hullu JA et al. Sentinel node dissection is safe in the treatment of early-stage vulvar cancer. J. Clin. Oncol. 2008 26 884 889.
11. Moore RG, Granai CO, Gajewski W, Gordinier M, Steinhoff MM. Pathologic evaluation of inguinal sentinel lymph nodes in vulvar cancer patients: a comparison of immunohistochemical staining versus ultrastaging with hematoxylin and eosin staining. Gynecol. Oncol. 2003 91 378 382.
12. Moore RG, Robison K, Brown AK et al. Isolated sentinel lymph node dissection with conservative management in patients with squamous cell carcinoma of the vulva: a prospective trial. Gynecol. Oncol. 2008 109 65 70.
13. Tjin Asjoe FM, van Bekkum E, Ewing P, Burger CW, Ansink AC. Sentinel node procedure in vulvar squamous cell carcinoma: a histomorphologic review of 32 cases. The significance of anucleate structures on immunohistochemistry. Int. J. Gynecol. Cancer 2008 18 1032 1036.
14. Tamussino K, Bader AA, Regauer S. Do we need immunohistochemistry to evaluate sentinel lymph nodes in vulvar cancer? Gynecol. Oncol. 2008 111 158 author reply 159.
15. de Hullu JA, Hollema H, Piers DA et al. Sentinel lymph node procedure is highly accurate in squamous cell carcinoma of the vulva. J. Clin. Oncol. 2000 18 2811 2816.
16. Terada KY, Shimizu DM, Wong JH. Sentinel node dissection and ultrastaging in squamous cell cancer of the vulva. Gynecol. Oncol. 2000 76 40 44.
17. Sobin LH, Wittekind C (eds). TNM classification of malignant tumours. UICC. New York : John Wiley & Sons, 2002 10 11.
18. Messerini L, Cianchi F, Cortesini C, Comin CE. Incidence and prognostic significance of occult tumor cells in lymph nodes from patients with stage IIA colorectal carcinoma. Hum. Pathol. 2006 37 1259 1267.
19. Bleiweiss IJ, Nagi CS, Jaffer S. Axillary sentinel lymph nodes can be falsely positive due to iatrogenic displacement and transport of benign epithelial cells in patients with breast carcinoma. J. Clin. Oncol. 2006 24 2013 2018.
20. Regauer S. Immune dysregulation in lichen sclerosus. Eur. J. Cell Biol. 2005 84 273 277.
21. Lukowsky A, Muche JM, Sterry W, Audring H. Detection of expanded T cell clones in skin biopsy samples of patients with lichen sclerosus et atrophicus by T cell receptor-gamma polymerase chain reaction assays. J. Invest. Dermatol. 2000 115 254 259.
22. Regauer S, Beham-Schmid C. Detailed analysis of the T-cell lymphocytic infiltrate in penile lichen sclerosus: an immunohistochemical and molecular investigation. Histopathology 2006 48 730 735.
23. Regauer S, Reich O, Beham-Schmid C. Monoclonal gamma-T-cell receptor rearrangement in vulvar lichen sclerosus and squamous cell carcinomas. Am. J. Pathol. 2002 160 1035 1045.
24. Regauer S, Beham-Schmid C. Monoclonally rearranged gamma T-cell receptor in lichen sclerosus - a finding of clinical significance? Am. J. Dermatopathol. 2004 26 349 350 author reply 350-351; discussion 351.
25. Van der Zee AG, Oonk MK, De Hullu JA et al. Sentinel node dissection is safe in the treatment of early-stage vulvar cancer. J. Clin. Oncol. 2008 26 884 889.